Sameness: The regulatory crux with nanomaterial identity and grouping schemes for hazard assessment

Regulatory Toxicology and Pharmacology

Volumn 72, Issue 3, 2015, Pages 569-571

  Walser, Tobias ^a   Studer, Christoph ^a  

^a FEDERAL OFFICE OF PUBLIC HEALTH   (Switzerland)

Author keywords

Entity of nanomaterials; Grouping; Hazard assessment of nanomaterials; Identity of nanomaterials; Regulatory toxicology; Sameness; Testing strategy

Indexed keywords

NANOMATERIAL;

CHEMICAL COMPOSITION; ENVIRONMENTAL EXPOSURE; HAZARD ASSESSMENT; MATERIAL COATING; NOTE; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SURFACE PROPERTY; CLASSIFICATION; HUMAN; TOXICITY TESTING;

HUMANS; NANOSTRUCTURES; RISK ASSESSMENT; TOXICITY TESTS;

EID: 84930946895     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2015.05.031     Document Type: Note

References (19)

1. Arts J.H.E., et al. A critical appraisal of existing concepts for the grouping of nanomaterials. Regul. Toxicol. Pharmacol. 2014, 70(2):492-506.
2. Arts J.H.E., et al. A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping). Regul. Toxicol. Pharmacol. 2015, (available online first).
3. Cohen J.M., et al. Tracking translocation of industrially relevant engineered nanomaterials (ENMs) across alveolar epithelial monolayers in vitro. Nanotoxicology 2014, 8(S1):216-225.
4. Donaldson K., et al. Pulmonary toxicity of carbon nanotubes and asbestos - Similarities and differences. Adv. Drug Deliv. Rev. 2013, 65(15):2078-2086.
5. European Chemicals Agency (2012). How to report read-across and categories. Practical Guide 6 ECHA-10-B-11.1-EN.
6. European Commission (2011a). REACH Implementation Project Specific Advice on Exposure Assessment and Hazard/Risk Characterisation for Nanomaterials under REACH on Nanomaterials (RIP-oN 3). RNC/RIP-oN3/FPR/1/FINAL.
7. European Commission (2011b). Commission Recommendation of 18 October 2011 on the definition of nanomaterial. 2011/696/EU, pp. 38-40.
8. Godwin H., et al. Nanomaterial characterization for assessing risk potential to facilitate regulatory decision-making. ACS Nano 2015, (published online 10.1021/acsnano.5b0094).
9. Lynch I., et al. A strategy for grouping of nanomaterials based on key physico-chemical descriptors as a basis for safer-by-design NMs. Nano Today 2014, 9(3):266-270.
10. Nano Support Project, (2012). Scientific technical support on assessment of nanomaterials in REACH registration dossiers and adequacy of available information. See: http://ec.europa.eu/environment/chemicals/nanotech/pdf/jrc_report.pdf.
11. Nel A.E., et al. A multi-stakeholder perspective on the use of alternative test strategies for nanomaterial safety assessment. ACS Nano 2013, 7(8):6422-6433.
12. Organisation for Economic Co-operation and Development OECD (2013). Recommendation of the Council on the Safety Testing and Assessment of Manufactured Nanomaterials C (2013) 107.
13. Organisation for Economic Co-operation and Development OECD (2014). Guidance on Grouping of Chemicals, second edition. Series on Testing and Assessment No. 194.
14. REACH Regulation (EC) No 1907/2006.
15. Rejman J., et al. Size-dependent internalization of particles via the pathways of clathrin and caveolae-mediated endocytosis. Biochemical Journal 2004, 377:159-169.
16. Schwirn K., et al. Why are nanomaterials different and how can they be appropriately regulated under REACH?. Environmental Sciences Europe 2014, 26:4.
17. Scott-Fordsmand J.J., et al. A unified framework for nanosafety is needed. Nano Today 2014, 9(5):546-549.
18. Thorley A.J. Critical determinants of uptake and translocation of nanoparticles by the human pulmonary alveolar epithelium. ACS Nano 2014, 8(11):11778-11789.
19. Zhang H., et al. Use of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammation. ACS Nano 2012, 6(5):4349-4368.